Intermittent claudication (IC) is caused by a blockage in the artery of the leg, causing muscle pain. Although some evidence of the efficacy of neuromuscular electrical stimulation (NMES) in the management of patients with IC exists, further high quality research is required. This proposed study is vital to identify the contribution of clinical change using NMES, compared to the current gold standard recommended practice of supervised exercise therapy (SET) and, actual standard of care offered in the majority of the UK and Ireland, including best medical therapy (BMT). The device is expected to increase the walking distance in patients with intermittent claudication (IC), and therefore have a benefit on the same when provided in addition to supervised exercise programmes. It is also expected to cause a reduction in pain symptoms and reduced likelihood of major intervention in late stage peripheral arterial disease (PAD). The principal research objective is to assess the clinical efficacy of a neuromuscular electrical stimulation (NMES) device as an adjunct to the local standard care that is available at the study randomisation sites, in order to improve walking distance in patients with intermittent claudication (IC).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
200
NMES device to be used for up to 3 hours daily in 30 minute sessions for 3 months.
The Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust
Bournemouth, United Kingdom
North Bristol NHS Trust
Bristol, United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Dorset County Hospital NHS Foundation Trust
Dorchester, United Kingdom
Hull and East Yorkshire Hospitals NHS Foundation Trust
Hull, United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom
St George's University Hospitals NHS Foundation Trust
London, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle, United Kingdom
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom
...and 1 more locations
Difference in the Absolute Walking Distance (AWD) at 3 Months Between the Two Treatment Groups
Measured by treadmill testing. Absolute walking distance in meters at baseline and 3 months
Time frame: 3 months
Difference in the Initial Claudication Distance (ICD) at 3 Months Between the Two Treatment Groups
Measured by treadmill testing. ICD in meters at baseline and 3 months
Time frame: 3 months
Quality of Life - Intermittent Claudication Questionnaire (ICQ)
Patient questionnaire. Used to assess change in disease-specific QoL.
Time frame: Baseline, 3 months, 6 months, 12 months
Quality of Life - EuroQoL 5D (EQ5D) Health Scale
Patient questionnaire. Used to assess the generic QoL and will allow economic assessment based on intervention and score improvement.
Time frame: Baseline, 3 month, 6 month and 12 months
Quality of Life Short Form 36 (SF-36) Physical Component Summary
Patient questionnaire. Used to assess the generic QoL and will allow economic assessment based on intervention and score improvement.
Time frame: Baseline, 3 month, 6 month and 12 months
Haemodynamic Assessment - Duplex Ultrasonography - Difference in Volume Flow Between Baseline and 3 Months
Using an arterial ultrasound probe and pre-set volume flow algorithms on a duplex ultrasound machine, flow within the common femoral artery (CFA), of the most affected limb, will be measured, approximately 5cm below the mid-inguinal point at the groin. Measures include volume flow (VF, cc/min) to assess whether using the device increases this measurement.
Time frame: 3 months
Haemodynamic Assessment - Laser Doppler Flowmetry (LDF) - Difference in Blood Flux Between Baseline and 12 Months
The single fibre laser optical probe of the LDF machine will be positioned on the dorsal aspect of the foot using single use adhesive pads. Flux, as a measure of superficial skin blood flow will be measured to assess whether using the device increases this measurement.
Time frame: Baseline, 3 month, 6 month and 12 months
Haemodynamic Assessment - Difference in Ankle Brachial Pressure Index (ABPI) - Left - Between Baseline and 12 Months
The brachial blood pressure from the right arm using a manual blood pressure monitor cuff and Doppler will be recorded after 5 minutes of resting supine on a couch. The systolic blood pressure of the anterior tibial artery and posterior tibial artery at the ankle will also be recorded using the cuff and Dopplermethod. The ratio of the systolic brachial and ankle pressures will form the ABPI measurement.
Time frame: Baseline, 3 month, 6 month and 12 months
Health Economic Assessment
The economic analyses will compare local therapy (supervised exercise therapy (SET) or exercise advice (EA) only) versus the intervention (local therapy + Neuromuscular Electrical Stimulation, NMES) in patients with Intermittent Claudication. The analyses will be based on a (i) patient level in-trial cost-effectiveness analysis, (ii) a decision model and (iii) budget impact assessment. The in-trial analysis will calculate quality-adjusted life years (QALYs) over the one year time horizon of the trial.
Time frame: Baseline, 3 month, 6 month and 12 months
Compliance With Interventions - Exercise Advice (EA)
Comparison of compliance with exercise advice as per local standard of care.
Time frame: 3 months
Device Experience Questionnaire - Ease of Use
To report ease of device use and suggest any developments.
Time frame: 3 months
Quality of Life - EuroQoL 5D (EQ5D) Health Index
Patient questionnaire. Used to assess the generic QoL and will allow economic assessment based on intervention and score improvement.
Time frame: Baseline, 3 months, 6 months, 12 months
Quality of Life Short Form 36 (SF-36) Mental Component Summary
Patient questionnaire. Used to assess the generic QoL and will allow economic assessment based on intervention and score improvement.
Time frame: Baseline, 3 months, 6 months, 12 months
Haemodynamic Assessment - Duplex Ultrasonography - Difference in Time Average Mean Velocity Between Baseline and 3 Months
Using an arterial ultrasound probe and pre-set volume flow algorithms on a duplex ultrasound machine, flow within the common femoral artery (CFA), of the most affected limb, will be measured, approximately 5cm below the mid-inguinal point at the groin. Measures include time-averaged mean volume (TAMV, cm/s) to assess whether using the device increases this measurement.
Time frame: 3 months
Haemodynamic Assessment - Difference in Ankle Brachial Pressure Index (ABPI) - Right - Between Baseline and 12 Months
The brachial blood pressure from the right arm using a manual blood pressure monitor cuff and Doppler will be recorded after 5 minutes of resting supine on a couch. The systolic blood pressure of the anterior tibial artery and posterior tibial artery at the ankle will also be recorded using the cuff and Dopplermethod. The ratio of the systolic brachial and ankle pressures will form the ABPI measurement.
Time frame: Baseline, 3 months, 6 months and 12 months
Compliance With Interventions - Supervised Exercise Therapy (SET)
Comparison of compliance with SET classes.
Time frame: 3 months
Compliance With Interventions - Neuromuscular Electrical Stimulation (NMES)
Compliance with NMES device. NMES compliance data collected from the data logger fitted to device and patient diary will be combined to report overall compliance.
Time frame: 3 months
Device Experience Questionnaire - Reduces Leg Pain
To report ease of device use and suggest any developments.
Time frame: 3 months
Device Experience Questionnaire - Increased Walk Distance
To report ease of device use and suggest any developments.
Time frame: 3 months
Device Experience Questionnaire - Used as Instructed
To report ease of device use and suggest any developments.
Time frame: 3 months
Device Experience Questionnaire - Could Have Used More
To report ease of device use and suggest any developments.
Time frame: 3 months
Device Experience Questionnaire - Used After Treatment
To report ease of device use and suggest any developments.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.